SCHEMBL25423216

SCHEMBL25423216

CC(C)N(C)C(=O)C(=O)c1c[nH]c2ccc(F)c(F)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.40
▸ HTR2A P28223 2/20 0.35
▸ HTR6 P50406 2/20 0.35
▸ HTR7 P34969 3/20 0.35
▸ HTR1A P08908 2/20 0.35
▸ PRKAB2 O43741 3/20 0.33
▸ PRKAG1 P54619 3/20 0.33
▸ PRKAA2 P54646 3/20 0.33
▸ PRKAA1 Q13131 3/20 0.33
▸ PRKAG3 Q9UGI9 3/20 0.33
▸ PRKAG2 Q9UGJ0 3/20 0.33
▸ PRKAB1 Q9Y478 3/20 0.33
▸ CES2 O00748 1/20 0.33
▸ CES1 P23141 1/20 0.33
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25748755 0.88 GPR84 (0.41) GPR84HTR2AHTR6HTR7HTR1A
SCHEMBL25422956 0.85 HTR1A (0.47) HTR6HTR7HTR1APRKAB2PRKAG1
SCHEMBL25435471 0.82 GPR84 (0.43) GPR84HTR2AHTR6HTR7HTR1A
SCHEMBL25748750 0.80 GPR84 (0.44) GPR84HTR2AHTR6HTR7HTR1A
SCHEMBL25748782 0.79 HTR1A (0.36) HTR1ACES2CES1HPGDHSD17B10
SCHEMBL25748962 0.79 TNF (0.33) CES2CES1ALDH1A1
SCHEMBL25423229 0.76 NR4A2 (0.33) CYP2C9ALDH1A1KMT2A
SCHEMBL29206556 0.76 GPR84 (0.40) GPR84HTR2AHTR6HTR7HTR1A
SCHEMBL25747864 0.76 HTR1A (0.35) HTR1AALDH1A1
SCHEMBL25241237 0.76 GPR84 (0.47) GPR84HTR2AHTR6HTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101038-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-03-27 — — US disclosed
EP-4452937-A1 COMPOUNDS Psylo Pty Ltd (AU) 2024-10-30 — — EP disclosed
CN-118715204-A Compounds of formula (I) 普赛洛私人有限公司 2024-09-27 — — CN disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101038-A1 COMPOUNDS NLN, SLC18A2, PYGB GPR84 3280/4885HTR2A 94/4885HTR6 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback